Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. Issue 4 (9th November 2021)

• Record Type: Journal Article
• Authors: Prunas, Ottavia; Weinberger, Daniel M; Medini, Duccio; Tizzoni, Michele; Argante, Lorenzo
• Is Part Of: American journal of epidemiology. Volume 191:Issue 4(2022)
• Page Start: 724
• Page End: 734
• Publication Date: 2021-11-09
• Subjects: effectiveness -- interrupted time series analysis -- invasive meningococcal disease -- meningococcal infections -- synthetic controls -- vaccine impact -- vaccines; Epidemiology -- Periodicals; Public health -- Periodicals; 614.4
• DOI: 10.1093/aje/kwab266
• Languages: English
• ISSNs: 0002-9262

Abstract

Abstract: Invasive meningococcal disease (IMD) has a low and unpredictable incidence, presenting challenges for real-world evaluations of meningococcal vaccines. Traditionally, meningococcal vaccine impact is evaluated by predicting counterfactuals from pre-immunization IMD incidences, possibly controlling for IMD in unvaccinated age groups, but the selection of controls can influence results. We retrospectively applied a synthetic control (SC) method, previously used for pneumococcal disease, to data from 2 programs for immunization of infants against serogroups B and C IMD in England and Brazil. Time series of infectious/noninfectious diseases in infants and IMD cases in older unvaccinated age groups were used as candidate controls, automatically combined in a SC through Bayesian variable selection. SC closely predicted IMD in absence of vaccination, adjusting for nontrivial changes in IMD incidence. Vaccine impact estimates were in line with previous assessments. IMD cases in unvaccinated age groups were the most frequent SC-selected controls. Similar results were obtained when excluding IMD from control sets and using other diseases only, particularly respiratory diseases and measles. Using non-IMD controls may be important where there are herd immunity effects. SC is a robust and flexible method that addresses uncertainty introduced when equally plausible controls exhibit different post-immunization behaviors, allowing objective comparisons of IMD programs between countries.